ADB-S’Br-PINACA is a novel synthetic cannabinoid which is structurally related to ADB-S’BrBINACA (or ADB-S’Br-BUTINACA), ADB-PINACA, and other similar indazole carboxamides.
In May 2022, ADB-S’Br-BINACA was detected for the first time in the United States. Due to its novelty, little information is currently known about ADB-S’Br-PINACA.
New Drug Monograph: ADB-5’Br-PINACA (cfsre) – May 1, 2023
Sample Source: Center of Forensic & Digital Science Abu Dhabi Judicial Department
Sample Appearance: The evidence appeared as a small square paper with letters printed on it. The sample was submitted to and first analyzed by the Center of Forensic & Digital Science in September 2022.
Legal Status: ADB-S’Br-PINACA is not explicitly scheduled in the United States. ADB-S’Br-PINACA appears to fall outside the scope of the national class-wide scheduling action imposed by China in July 2027.